相关实验视频

Updated: May 21, 2025

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

Published on: June 15, 2011

对DEPDC5基因突变的基因型和临床表型分析

Baoguang Li^1,2, Zhenzhen Qu³, Wenjuan Wu^2,4

¹Graduate School of Hebei Medical University, Shijiangzhuang, China.

|March 18, 2025

概括

DEPDC5基因突变导致焦点发作,特别是截断突变. 拉科萨米德治疗在患有DEPDC5突变的患者中显示出有前途.

科学领域:

遗传学遗传学是一个
神经学神经学

背景情况:

DEPDC5基因的突变与自体主导遗传有关,可以表现为焦点发作.
虽然报告了DEPDC5突变,但功能验证研究有限.

研究的目的:

分析7名DEPDC5突变患者的临床和遗传数据.
调查新型DEPDC5突变的功能影响,并评估治疗反应.

主要方法:

对七名患有或由于DEPDC5突变而导致发育障碍的患者的临床病例分析.
突变部位的遗传分析,包括无意义,错误和拼接部位突变.
微基因实验以确认拼接位突变的致病性.

主要成果:

七名患有DEPDC5突变的患者出现焦点发作,发病时间在2个月至4年之间.
确定了6个突变部位,其中包括3个新突变. 迷你基因检测证实了拼接部位突变的致病性.
切断DEPDC5突变与耐药性有关;四名患者对lacosamide反应良好.

结论:

DEPDC5突变是焦点的原因,截断变异与更严重的表型有关.
拉科萨米德显示出作为与DEPDC5突变相关的的有效治疗潜力.

关键词:

在DEPDC5基因.焦点性发作焦点性发作拉科萨米德是一种乳胺.

更多相关视频

High Content Screening in Neurodegenerative Diseases

High Content Screening in Neurodegenerative Diseases

Published on: January 6, 2012

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

相关概念视频

Pedigree Analysis

Pedigree Analysis

Incomplete Dominance

Incomplete Dominance

Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.